Incyte
INCY
#987
Rank
S$30.49 B
Marketcap
S$149.61
Share price
-1.64%
Change (1 day)
13.06%
Change (1 year)

Incyte (INCY) - Total liabilities

Total liabilities on the balance sheet as of September 2026 : S$2.12 Billion

According to Incyte's latest financial reports the company's total liabilities are S$2.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Incyte - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$2.29 B-15.3%
2024-12-31S$2.71 B29.06%
2023-12-31S$2.10 B6.65%
2022-12-31S$1.97 B25.38%
2021-12-31S$1.57 B25.19%
2020-12-31S$1.25 B12.5%
2019-12-31S$1.11 B13.57%
2018-12-31S$0.98 B9.41%
2017-12-31S$0.89 B-49.06%
2016-12-31S$1.76 B49.16%
2015-12-31S$1.18 B1.95%
2014-12-31S$1.16 B11.32%
2013-12-31S$1.04 B68.65%
2012-12-31S$0.61 B-14.18%
2011-12-31S$0.72 B-3.32%
2010-12-31S$0.74 B-34.89%
2009-12-31S$1.14 B76.51%
2008-12-31S$0.64 B3.47%
2007-12-31S$0.62 B-6.86%
2006-12-31S$0.67 B2.63%
2005-12-31S$0.65 B-8.39%
2004-12-31S$0.71 B86.92%
2003-12-31S$0.38 B-11.7%
2002-12-31S$0.43 B-11.79%
2001-12-31S$0.49 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
S$102.75 B 4,739.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$149.31 B 6,932.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$139.19 B 6,455.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$108.39 B 5,005.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$1.57 B-25.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
S$0.38 B-81.73%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
S$0.17 B-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$93.46 M-95.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
S$0.55 B-74.04%๐Ÿ‡บ๐Ÿ‡ธ USA